MONDAY, Aug. 19, 2024 (HealthDay News) — Iron deficiency isn’t being effectively treated in the United States, with low iron levels persisting for years in most patients, a new study finds. Almost 3 of 5 (58%) patients with iron deficiency still had low iron levels three years after their diagnosis,Continue Reading
TUESDAY, June 18, 2024 (HealthDay News) — There’s more good news in the battle against sickle cell disease, with another trial finding CRISPR gene-editing therapy delivering impressive results for patients. “It’s encouraging that this gene-editing treatment continues to show promising efficacy for sickle cell patients,” said study lead investigator Dr.Continue Reading
TUESDAY, March 5, 2024 (HealthDay News) — Long COVID might be triggered by low iron levels in the blood from the person’s initial infection, a new study claims. It’s remained a mystery why an estimated three out of 10 people infected with COVID go on to suffer lingering symptoms likeContinue Reading
FRIDAY, Jan. 26, 2024 (HealthDay News) — Too many American tourists looking for cheap cosmetic surgeries alongside their beach time are winding up dead in the Dominican Republic, a new report finds. Between 2009 and 2022, 93 people — almost all young or middle-aged women — have died after undergoingContinue Reading
WEDNESDAY, Jan. 17, 2024 (HealthDay News) — Casgevy, a groundbreaking treatment that was approved to treat sickle cell disease in December, was given the U.S. Food and Drug Administration’s blessing on Tuesday to treat another inherited blood disorder. Casgevy is the first CRISPR-based medicine, where gene editing is used toContinue Reading
FRIDAY, Jan. 12, 2024 (HealthDay News) — Sickle cell disease is one of many chronic health conditions that dramatically increases the risk of hospitalization and death in people infected by COVID-19. Unfortunately, folks with sickle cell disease are much less likely to have received the best protection available to themContinue Reading
FRIDAY, Dec. 8, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Friday approved two milestone gene therapies for sickle cell disease, including the first treatment ever approved that uses gene-editing technology. Casgevy, developed by Vertex Pharmaceuticals of Boston and CRISPR Therapeutics of Switzerland, is the first medicineContinue Reading
MONDAY, Nov. 20, 2023 (HealthDay News) — Lab-grown blood vessels are providing new insight into how damage to the tiny vessels in the brain can cause them to leak, contributing to dementia and stroke. Even better, this research has identified a drug target that could plug these leaks and potentiallyContinue Reading
WEDNESDAY, Nov. 1, 2023 (HealthDay News) — A new gene therapy for sickle cell disease was deemed safe by a U.S. Food and Drug Administration advisory panel on Tuesday, paving the way for full approval by early December. The FDA had already decided that the therapy, known as exa-cel, was effective.Continue Reading
MONDAY, Oct. 30, 2023 (HealthDay News) — Patients with sickle cell disease may soon have two new treatments to try. On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a new gene therapy for the painful, inherited condition, which typically strikes Black people. The agencyContinue Reading